Taking yeast infection medication without an infection induces drug resistance
the verdict
INSUFFICIENT LEANING
refutedsupported
the weight of evidence
2 sources for · 0 against
Available sources indicate that improper or inappropriate use of antifungal medications can contribute to the development of antifungal resistance, but specific evidence demonstrating that taking these drugs without an infection actively induces resistance is lacking.
nt Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy This problem is a type of antimicrobial resistance . It occurs when fungi, viruses, bacteria and parasites don’t respond to medications developed to treat them. Your body doesn’t develop antifungal resistance — fungi do. Today, while antifungal medicines may still help you, fewer drugs can treat drug-resistant fungi. What are antifungal medications? Antifungal drugs help your body get rid of certain fungal infections. They treat fungal skin infections like yeast infections , athlete’s foot, jock itch and ringworm . Antifungal medicines also manage infections that affect the lungs, brain and blood. Why is antifungal resistance a problem? Drug resistance is a serious global health problem. It greatly limits treatment options. If a fungus doesn’t respond to one of three available classes of antifungal drugs, the other options may be less effective. Some drugs cause more severe, potentially toxic side effects. Nearly 3 million Americans will develop a drug-resistant infection this year. More than 35,000 of them will die. What causes antifungal resistance? There are several causes of antifungal resistance: Improper use of antifungal medicines: When you skip doses, stop treatment too soon or receive a dose that’s too low, a fungus gets better at fighting off the medicine’s effects. Antibiotic use: Antibiotics kill harmful bacteria. But they can also kill helpful bacteria in the digestive tract . As a result, Candida , a yeast naturally found inside the digestive tract, can start to grow too fast. A person taking antibiotics may then need antifungals to treat a yeast infection called candidiasis. Frequent treatment raises the risk of drug resistance to both treatments. Fungicide use: People who work closely with crops treated by fungicides may be more prone to fungal infections that are antifunga
losis . In some parts of the world, estimates of fluconazole resistance are over 30%.
Spread in healthcare facilities
C. parapsilosis and C. auris spread among patients and cause outbreaks.
Emerging drug-resistant C. parapsilosis
CDC's Emerging Infections Program (EIP) conducts population- and laboratory-based surveillance of Candida bloodstream infections (candidemia) at 10 sites. EIP data, presented below, show the percentage of all C. parapsilosis specimens from bloodstream infections that were fluconazole-resistant each year.
Noninvasive infections
Non-invasive infections are Candida infections that do not affect the blood or internal organs. Based on limited data, fluconazole resistance is a concern in vulvovaginal candidiasis (VVC), a common non-invasive infection.
There is not enough evidence on antifungal resistance in other types of non-invasive candidiasis, like oropharyngeal Candida infections ("thrush"), but it is possible that some infections are resistant.
It is challenging to get data on non-invasive infections for a few reasons:
Healthcare providers typically do not order laboratory tests for noninvasive infections.
Some people use over-the-counter antifungal products or never seek medical care.
How to stop emerging resistance
Everyone can help prevent the rise of drug-resistant candidiasis by using antifungals appropriately.
There are two main ways to help stop the emergence of drug resistance:
Reducing invasive infections by implementing recommended infection prevention and control practices.
Using antifungals appropriately (antifungal stewardship). This means giving patients the right drug at the appropriate dose for the correct amount of time.
What healthcare providers can do
Healthcare providers can help prevent the emergence of resistant Candida infections by:
Using diagnostic testing, including species identification and antifungal susceptibility testing, to guide treatment of infections.
Diagnostic testing is critical for invasive infections,
Everything we examined (2)
This check searched the claim as stated. It did not run a separate search for evidence against it.